BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30714528)

  • 21. The Emergence of HIV-1 Transmitted Drug Resistance Mutations Among Antiretroviral Therapy-naive Individuals in Buleleng, Bali, Indonesia.
    Megasari NLA; Oktafiani D; Fitriana E; Khairunisa SQ; Kotaki T; Ueda S; Nasronudin N; Soetjipto S; Kameoka M
    Acta Med Indones; 2019 Jul; 51(3):197-204. PubMed ID: 31699942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Survey of HIV-1 drug resistance threshold in Shandong Province in 2013-2015].
    Sun XG; Yu HY; Su SL; Lin B; Li JH; Lin L; Tao XR; Qian YS; Kang DM; Xing H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):604-609. PubMed ID: 28693084
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
    Cheung KW; Peng Q; He L; Cai K; Jiang Q; Zhou B; To SW; Yam WC; Liu L; Chen Z; Wang H
    PLoS One; 2016; 11(4):e0153641. PubMed ID: 27092551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypic Characterization of Human Immunodeficiency Virus Type 1 Isolated from Antiretroviral Treatment-Experienced Individuals in Buleleng Regency, Bali, Indonesia.
    Megasari NLA; Oktafiani D; Ana EF; Ueda S; Kotaki T; Nasronudin ; Soetjipto ; Kameoka M
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):769-774. PubMed ID: 31112033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.
    Steegen K; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; Variava E; MacLeod W; Sanne I; Stevens WS; Carmona S
    J Antimicrob Chemother; 2017 Jan; 72(1):210-219. PubMed ID: 27659733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of antiretroviral drug resistance in treatment-naive injecting drug users infected with HIV-1 in Guangzhou, 2008-2015].
    Xu LQ; Han ZG; Zhang YL; Wu H; Gao K; Li QM; Xu HF; Cai YS; Xia Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):196-201. PubMed ID: 30744272
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia.
    Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH
    Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
    Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
    PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda.
    Kityo C; Sigaloff KC; Sonia Boender T; Kaudha E; Kayiwa J; Musiime V; Mukuye A; Kiconco M; Nankya I; Nakatudde-Katumba L; Calis JC; Rinke de Wit TF; Mugyenyi PN
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):628-35. PubMed ID: 26723018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Dominance of CRF01_AE and the Emergence of Drug Resistance Mutations Among Antiretroviral Therapy-Experienced, HIV-1-infected Individuals in Medan, Indonesia.
    Indriati DW; Witaningrum AM; Yunifiar MQ; Khairunisa SQ; Ueda S; Kotaki T; Nasronudin N; Kameoka M
    Acta Med Indones; 2020 Oct; 52(4):366-374. PubMed ID: 33377882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
    Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
    J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.
    Li H; Liang S; Guo W; Zhuang D; Li L; Liu Y; Bao Z; Liu S; Wang X; Li T; Liu W; Li J
    J Virol Methods; 2014 Sep; 205():17-23. PubMed ID: 24814966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.
    Dokuta S; Utaipat U; Praparattanapan J; Keitkarn J; Maneekarn N; Sirisanthana T; Supparatpinyo K
    J Virol Methods; 2013 Jun; 190(1-2):20-8. PubMed ID: 23562659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
    Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China.
    Li Y; Gu L; Han Y; Xie J; Wang H; Lv W; Song X; Li Y; Iwamoto A; Ishida T; Li T;
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):289-97. PubMed ID: 25501612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Distribution of subtypes of pol gene in HIV-1 epidemic strains in Guangxi Zhuang Autonomous Region, 2010- 2012].
    Wang H; Liang B; Zhou B; Jiang J; Huang J; Chen R; Zhao F; Wang M; Liu J; Li W; Ye L; Liang H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jan; 50(1):79-84. PubMed ID: 26792508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Epidemiology of HIV-1 Subtypes and Primary Antiretroviral Resistance Profiles in Northern Cyprus: First Data Series.
    Guler E; Arikan A; Sultanoglu N; Suer K; Sanlidag T; Sayan M
    AIDS Res Hum Retroviruses; 2024 Jun; 40(6):393-400. PubMed ID: 38366753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand.
    Auwanit W; Isarangkura-Na-Ayuthaya P; Kasornpikul D; Ikuta K; Sawanpanyalert P; Kameoka M
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):625-31. PubMed ID: 19500016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
    Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
    BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.